Drugs / Seasonal LAIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02950688 | ? → Dec 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal LAIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02950688 ↗ |
| Modality | Vaccine | “seasonal live attenuated influenza vaccine (LAIV)” NCT02950688 ↗ |
| Route | Intranasal | “administered by intranasal spray” NCT02950688 ↗ |